Home › NDC Lookup › RxCUI directory › RxCUI 876519

Amlodipine 10 MG / telmisartan 80 MG Oral Tablet — RxCUI 876519

RxNorm drug concept · Semantic clinical drug
RxCUI 876519 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI876519
Official nameAmlodipine 10 MG / telmisartan 80 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asamlodipine (as amlodipine besylate) 10 MG / telmisartan 80 MG Oral Tablet
FDA products mapped10
Package NDCs mapped8
Reported Medicaid activity (SDUD)1,606 prescriptions · 8 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Telmisartan: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Telmisartan is used for two main reasons. First, it treats high blood pressure — bringing your numbers down protects you from strokes and heart attacks. Second, for people 55 and o...
  • You take telmisartan once a day, and it can be taken with or without food — whichever fits your routine best. The most important thing is to take it at roughly the same time every...
  • When should I take it, and does it matter if I take it with food?
  • Most people do fine on telmisartan. Back pain, a stuffy or sore throat, mild diarrhea, or a runny nose are the more common, minor complaints. What you really need to call about rig...
📖 Read our full Telmisartan guide →

🕸️ Concept Web — How Amlodipine 10 MG / telmisartan 80 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Amlodipine 10 MG / telmisartan 80 MG Oral Tablet RxCUI 876519

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 3

    The active substance itself — no strength, form, or brand attached yet.

    • Amlodipine 17767
    • Telmisartan 73494
    • Amlodipine / telmisartan 901212
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Twynsta 1372734
  3. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Amlodipine / telmisartan Oral Tablet 876513
    • Amlodipine / telmisartan Oral Product 1152287
    • Amlodipine / telmisartan Pill 1152288
    • Amlodipine / telmisartan Oral Tablet [Twynsta] 876517
    • Twynsta Oral Product 1186905
    • Twynsta Pill 1186904
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  4. Clinical & branded drugs 4

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Amlodipine 10 MG 329526
    • Telmisartan 80 MG 316765
    • Amlodipine 10 MG / telmisartan 80 MG Oral Tablet [Twynsta] 876523
    • Amlodipine 10 MG / telmisartan 80 MG [Twynsta] 876521

Showing up to 8 concepts per family — 16 of 17 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Amlodipine 10 MG SCDC · 329526
  • Telmisartan 80 MG SCDC · 316765
  • Amlodipine / telmisartan Oral Tablet SCDF · 876513
  • Amlodipine / telmisartan Oral Product SCDG · 1152287
  • Amlodipine / telmisartan Pill SCDG · 1152288

Brand-Name Concepts

  • Amlodipine 10 MG / telmisartan 80 MG Oral Tablet [Twynsta] SBD · 876523
  • Amlodipine 10 MG / telmisartan 80 MG [Twynsta] SBDC · 876521
  • Amlodipine / telmisartan Oral Tablet [Twynsta] SBDF · 876517
  • Twynsta Oral Product SBDG · 1186905
  • Twynsta Pill SBDG · 1186904
  • Twynsta BN · 1372734

📦 FDA Products & Package NDCs

10 products · 8 package NDCs
8 package NDCs map to RxCUI 876519 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00378-1075-93 30 TABLET in 1 BOTTLE, PLASTIC (0378-1075-93) Telmisartan and Amlodipine Mylan Pharmaceuticals Inc. 2014-09-19
00378-1076-93 30 TABLET in 1 BOTTLE, PLASTIC (0378-1076-93) Telmisartan and Amlodipine Mylan Pharmaceuticals Inc. 2014-09-19
00378-1077-93 30 TABLET in 1 BOTTLE, PLASTIC (0378-1077-93) Telmisartan and Amlodipine Mylan Pharmaceuticals Inc. 2014-09-19
00378-1078-93 30 TABLET in 1 BOTTLE, PLASTIC (0378-1078-93) Telmisartan and Amlodipine Mylan Pharmaceuticals Inc. 2014-09-19
46708-0184-08 80 BLISTER PACK in 1 CARTON (46708-184-08) / 8 TABLET in 1... Telmisartan and Amlodipine Alembic Pharmaceuticals Limited 2016-11-22
46708-0185-08 80 BLISTER PACK in 1 CARTON (46708-185-08) / 8 TABLET in 1... Telmisartan and Amlodipine Alembic Pharmaceuticals Limited 2016-11-22
46708-0186-06 60 BLISTER PACK in 1 CARTON (46708-186-06) / 6 TABLET in 1... Telmisartan and Amlodipine Alembic Pharmaceuticals Limited 2016-11-22
46708-0187-06 60 BLISTER PACK in 1 CARTON (46708-187-06) / 6 TABLET in 1... Telmisartan and Amlodipine Alembic Pharmaceuticals Limited 2016-11-22
Observed labelers: Alembic Pharmaceuticals Limited (4) · Mylan Pharmaceuticals Inc. (4) · +1 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.